Please provide your email address to receive an email when new articles are posted on . Interval FIT was positive in 14% to 17% of patients after colonoscopy, regardless of polypectomy history. High ...
A fecal immunochemical test (FIT) conducted 2 years apart could form the basis for population-based colorectal cancer screening if this approach goes on to show a mortality benefit, according to a ...
A cohort study of adults undergoing a colonoscopy after a positive fecal immunochemical testing (FIT) result suggest that endoscopists performing colonoscopy in FIT-based screening programs should aim ...
Adenoma detection rate (ADR) targets for endoscopists performing colonoscopy after a positive fecal immunochemical test (FIT) should be markedly higher compared with ADR targets used in primary ...
A study published in Gut examined whether annual fecal immunochemical testing could reduce reliance on surveillance colonoscopy. Researchers recruited immediate risk patients (between 60- and 72-years ...
Researchers investigated whether the time interval between a positive FIT result and follow-up colonoscopy is linked to risk for CRC.
A delay of up to 2 years for follow-up colonoscopy after a positive fecal immunochemical test (FIT) was not associated with an increased risk of advanced adenoma, colorectal cancer (CRC), or advanced ...
Please provide your email address to receive an email when new articles are posted on . Multi-target stool DNA screening tests predicted neoplasia at follow-up colonoscopy more often than fecal ...
A simulation model has shown a hybrid colorectal cancer screening process to be clinically and cost effective, according to The Oncology Report. The method includes an annual fecal immunological test ...
Certain barriers to colonoscopy completion among patients with abnormal fecal immunochemical test (FIT) results may be modifiable, a survey of healthcare workers at a safety net health system ...
Genetic risk assessment in primary care settings: An evaluation of NCCN guidelines. Summary of findings by varying f-Hb cut-offs where ≥10µg/g is FIT +.